| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 60,179 | 60,631 | 62,654 | 61,313 | | Cost of Revenue | 15,100 | 16,420 | 17,734 | 19,414 | | | Gross Profit | 45,079 | 44,210 | 44,920 | 41,899 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 26,504 | 29,730 | 24,484 | 20,301 | | Non Recurring |
-
|
-
|
-
| 1,497 | | Others | 22,911 | 66,196 | 14,368 | 4,498 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,335) | (51,716) | 6,068 | 15,603 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (4,335) | (51,716) | 6,068 | 15,603 | | Interest Expense | 2,794 | 3,096 | 3,084 | 3,967 | | Income Before Tax | (7,129) | (54,812) | 2,983 | 11,636 | | Income Tax Expense | (3,782) | (23,036) | 893 | 3,583 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (3,347) | (31,776) | 2,090 | 8,053 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (3,347) | (31,776) | 2,090 | 8,053 | | Preferred Stock And Other Adjustments | (1,504) | (1,470) | (1,447) | (309) | | | Net Income Applicable To Common Shares | ($4,851) | ($33,246) | $643 | $7,744 |
|
0.40% Nasdaq 
Income Statement
